A Phase 1 Study to Evaluate the Drug Interaction Between Islatravir (MK-8591) and Doravirine in Adults Without HIV

Matthews, RP; Rudd, DJ; Fillgrove, KL; Zhang, SJ; Tomek, C; Stoch, SA; Iwamoto, M

Matthews, RP (corresponding author), Merck & Co Inc, Kenilworth, NJ 07033 USA.

CLINICAL DRUG INVESTIGATION, 2021; 41 (7): 629

Abstract

Background and Objectives Islatravir (MK-8591) is a novel nucleoside analogue in development for the treatment and prevention of HIV-1 infection. Dora......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索